1st International Congress on Borderline Personality Disorder - esspd
←
→
Transkription von Seiteninhalten
Wenn Ihr Browser die Seite nicht korrekt rendert, bitte, lesen Sie den Inhalt der Seite unten
Plenarvo
rträge
werden si
multan
übersetzt
1st International Congress on
Borderline Personality Disorder
1 – 3 July 2010 // bcc Berliner Congress Center // Berlin
Accredited by the European Council for Continuing Medical Education (EACCME)
Accredited by the Ärztekammer Berlin with 15 CME credits
www.borderline-congress.org Final Programme
1
Contents
page page
3 Welcome Addresses / Grußworte 26 Scientific Programme by Day
Thursday, 1 July
10 Congress Organisation
41 Scientific Programme by Day
13 Format Descriptions, Topics Friday, 2 July
and Programme Structure
58 Scientific Programme by Day
14 Programme Overview Thursday, 1 July Saturday, 3 July
16 Programme Overview Friday, 2 July 60 Betroffenen-Diskussionsforum
18 Programme Overview Saturday, 3 July 61 Acknowlegdements
20 Scientific Programme by Topic 62 Congress Information
25 Plenary Sessions 65 The City of Berlin
66 Index of Authors and Chair Persons
Congress Language Kongresssprache
The official language of the 1st International Die offizielle Kongresssprache des 1st Internatio
Congress on Borderline Personality Disorder is nal Congress on Borderline Personality Disorder
English. A selection of sessions, marked with ist Englisch. Eine Auswahl an Veranstaltungen
, will be held in German. Sessions, marked findet in deutscher Sprache statt und ist ent
with , will be held in English. The Opening sprechend gekennzeichnet: . Englischsprachi
Ceremony as well as the Plenary Lectures and ge Veranstaltungen sind mit gekennzeichnet.
all sessions with will be translated simula- Die Eröffnungsveranstaltung sowie die Plenarvor
neously from English into German and vice- träge und Veranstaltungen, die mit gekenn
versa. zeichnet sind, werden simultan vom Englischen
ins Deutsche und umgekehrt übersetzt.
Congress Venue Local President and Scientific Contact
bcc Berliner Congress Center Thorsten Kienast, MD
Alexanderstr. 11, 10178 Berlin, Germany Schön Klinik Hamburg-Eilbek
S-Bahn and Underground station: Department of Psychiatry
Alexanderplatz Dehnhaide 120, 22081 Hamburg, Germany
Charité Campus Mitte
Congress President Charitéplatz 1, 10115 Berlin
Professor Martin Bohus, MD
Congress and Exhibition Office
Central Institute of Mental Health (CIMH) CPO HANSER SERVICE GmbH
J5 Paulsborner Str. 44
68159 Mannheim, Germany 14193 Berlin, Germany
Phone: +49 – 30 – 300 669-0
Fax: +49 – 30 – 300 669-50
Email: borderline-congress@cpo-hanser.de
Web: www.borderline-congress.org
2
Welcome Address
Dear Colleagues and Congress Visitors,
On behalf of the organising committee, I would like
to welcome you to Berlin. The city of Berlin itself
looks back on a long and sometimes painful history
as being “borderline” and yet it has since recovered
very well from these traumatic experiences. What
could be more appropriate then than to organise the
world’s first congress on this topic?
It really is the first time that a congress is taking place with the single
stated aim of discussing the current status of research into borderline
personality disorders. There are good reasons for this: people with bor-
derline personality disorder have spent many years largely ignored by
science, lurking in the “dirty corner” of psychiatry, and subjected to spec-
ulative ideas and inadequate treatment methods. The consequences for
those affected and their families have often been disastrous. Fortunately,
however, this is now history. Unlike any other mental disorder, our knowl-
edge about the origin, progress, phenomenology and neurobiology of
borderline personality disorders has multiplied in the last decade. The
treatment possibilities have also improved to such an extent that there are
now several competing, evidence-based treatment concepts available –
optimum conditions in fact. That said, we are certainly far from being
satisfied – only approximately 60 % of patients treated benefit from the
currently established procedures – but we have made a start. All of us
here today understand that only a critical examination of our knowledge
and the continuous exchange of information and ideas between basic re-
searchers, therapy developers, clinical therapists and those affected will
take us forward.
We must take this congress as an impetus for further growth – as we plan
to continue this meeting every two years. The time is ripe to accord those
with borderline personality disorder the position that is rightfully theirs in
the field of psychotherapeutic research and in healthcare provision; not
only to relieve the suffering of those affected and their family members
but to enable them to lead a life worth living.
Our thanks go to all the cooperating specialist associations and sponsors
who have placed their confidence in us as well as to the employees of
CPO HANSER SERVICE, who have capably and proficiently partnered us
in designing the congress.
Prof. Dr. Martin Bohus
Congress President
3
Grußwort
Sehr geehrte Kolleginnen und Kollegen,
liebe Kongressbesucherinnen und Besucher,
im Namen des Organisationskomitees heiße ich Sie
herzlich in Berlin willkommen. Die Stadt Berlin
schaut selbst auf eine lange und manchmal leidvolle
Geschichte als „border-line“ zurück und hat sich mitt
lerweile doch sehr gut von diesen traumatischen Er-
fahrungen erholt. Was liegt also näher, als den welt-
weit ersten Kongress zu dieser Thematik in Berlin zu veranstalten?
Es ist tatsächlich das erste Mal, dass ein Kongress stattfindet, dessen er
klärtes und alleiniges Ziel es ist, den derzeitigen Stand der Forschung zur
Borderline-Störung zu diskutieren. Das hat gute Gründe: verbrachte die
Borderline-Störung doch viele Jahre weitgehend unbeachtet von der Wis-
senschaft in der „Schmuddelecke“ der Psychiatrie und war durchsetzt mit
spekulativen Konzepten und insuffizienten Behandlungsmethoden. Die
Folgen für die Betroffenen und deren Familien waren oft verheerend.
Doch dies ist erfreulicherweise Geschichte. Wie in kaum einem zweiten
psychischen Störungsbild hat sich unser Wissen zu Entstehung, Verlauf,
Phänomenologie und Neurobiologie der Borderline-Störung in der letz-
ten Dekade vervielfacht. Auch die Möglichkeiten der Behandlung haben
sich so weit verbessert, dass gleich mehrere evidenz-basierte Behand-
lungskonzepte vorliegen und konkurrieren – optimale Bedingungen also.
Sicherlich sind wir weit davon entfernt, zufrieden zu sein, – nur etwa
60 % der behandelten Patienten profitieren von den derzeit etablierten
Verfahren – aber ein Anfang ist gemacht. Und wir alle, die wir hier sind,
haben verstanden, dass nur die kritische Überprüfung unseres Wissens
und der kontinuierliche Austausch zwischen Grundlagenforschern, The
rapieentwicklern, klinischen Therapeuten und den Betroffenen uns weiter
voran bringen wird.
Nehmen wir diesen Kongress als ein Signal zum Aufbruch, er wird von
nun an alle zwei Jahre seine Fortsetzung finden. Die Zeit ist reif, der Bor-
derline-Störung den Platz zuzuweisen, den sie im psychotherapeutischen
Forschungsfeld und in der gesundheitspolitischen Versorgung bean
sprucht, um so das Leid der Betroffenen und ihrer Angehörigen zu lindern
und ihnen ein lebenswertes Leben zu ermöglichen.
Unser Dank gilt allen kooperierenden Fachgesellschaften und Sponsoren
die uns ihr Vertrauen geschenkt haben sowie den Mitarbeitern des Unter
nehmens CPO HANSER SERVICE, unserem kompetenten Partner bei der
Gestaltung des Kongresses.
Prof. Dr. Martin Bohus
Kongresspräsident
4
Welcome Address
Dear Ladies and Gentlemen
As local organizer and on behalf of the local scientific
committee, I am honoured to welcome you to the
1st International Congress on Borderline Personality
Disorder. The congress gathers leading scientists
and clinicians from all over the world who will present
new and exciting findings. We are convinced that the
various symposia, lectures, practice seminars and
oral presentations will provide valuable insight into present and future
aspects of borderline personality disorder-related research and inspire
many fruitful discussions. We are looking forward to sharing with you this
opportunity to exchange knowledge, ideas, and experiences to work
together towards a better understanding and improved therapy for our
patients.
I would like to thank all those who have contributed to the successful
outcome of the congress, particularly the congress organisation CPO
Hanser Service GmbH.
I do hope that you will enjoy a few pleasant summer days in Berlin. Our
charming metropolis, where “East” meets “West”, has its own flair and
character and is well worth looking at.
Thorsten Kienast, MD, MBA
Local Congress President
5
Grußwort
Liebe Kolleginnen und Kollegen,
herzlich willkommen im Namen unserer Stadt und
des wissenschaftlichen Komittees zu unserem ersten
Internationalen Kongress zu Borderline Persönlich
keitsstörung, der in Berlin stattfinden darf. Wir möch
ten mit diesem Kongress Forschern und Mitarbeitern,
Therapeuten und Co-Therapeuten aller Berufsgrup-
pen, die an der Behandlung von Patienten mit Border-
line Persönlichkeitsstörung beteiligt sind, eine hervorragende Möglichkeit
für gegenseitigen Austausch geben. Es ist uns gelungen, national und
international führende Wissenschaftler und Therapeuten aus vielen Berei
chen dieses Forschungsgebietes, von Biologie zu Psychotherapie, von
Epidemiologie zu Ökonomie, für 3 Tage an einem Ort zu versammeln und
Austausch zu schaffen. Wir sind überzeugt, dass die einzelnen Veranstal
tungen wertvolle Einblicke in wissenschaftliche Hintergründe und her
vorragende Trainingsmöglichkeiten für Therapeuten bieten. Die Plenar-
vortäge werden in die Deutsche Sprache übersetzt.
Auf diesem Kongress feiert auch das Netzwerktreffen „Dialektisch Behav-
iorale Therapie“ sein 10-jähriges Bestehen. Hierzu möchten wir herzlich
gratulieren. Danken möchte ich an dieser Stelle allen Helferinnen und
Helfern, die diesen Kongress ermöglicht haben. Meinen ganz besonderen
Dank möchte ich dem organisierenden Kongressbüro CPO Hanser
Service aussprechen.
Ich freue mich sehr, Sie in diesem Sommer in unserer wundervollen,
lebenswerten Stadt Berlin begrüßen zu dürfen und wünsche Ihnen ein
herrliches privates Rahmenprogramm.
Dr. Thorsten Kienast, MBA
Lokaler Kongresspräsident
6
Welcome Addresses
Dear Colleagues,
This First International Congress on Borderline Per-
sonality Disorder is a milestone in the development
of the BPD concept as a clinically relevant nosologi-
cal entity in mental health care and research.
I remember well the first Conference on Borderline
Personality Disorder which was organized by the
Dutch Royal Academy of Science 20 years ago. It was a conference of pio-
neers with international speakers addressing the upcoming concept of the
borderline personality disorder. The BPD conference had an enormous
spinoff for treatment and for research on BPD in the Netherlands. Compar
able developments took place in many countries and many clinicians and
researchers from all over the world contributed to the tremendous growth
of knowledge regarding BPD. This is all the more remarkably, since per-
sonality disorders are not regarded as a major psychiatric disorder. In
most countries is it very hard to get funding for PD research and as a re-
sults in many countries PD is still a neglected and underdeveloped topic
for treatment and research.
We still have to work further on the emancipation of the Borderline Per-
sonality Disorder as a clinically relevant syndrome in order to generate
better research funding, to support all the mental health workers in their
difficult daily work, and to decrease the suffering of our BPD patients.
I hope that this conference with its excellent keynote speakers and out-
standing scientific program will inspire you as mental health workers,
researchers, and policymakers to contribute to the further development
and emancipation of Borderline Personlaty Disorder.
Enjoy the congress and I hope you all will have a great time in Berlin.
Dr. Thomas Rinne
Vice-President International Society for the Study of Personality Disorders
(ISSPD)
Founding-President European Society for the Study of Personality Disorders
(ESSPD)
7Welcome Address
On behalf of the American Psychiatric Association, it
is my pleasure to welcome you to the First Interna-
tional Congress on Borderline Personality Disorder.
BPD is a prevalent, disabling, and complex illness
that is often misunderstood. Too often, treatment for
patients with this disorder is inadequate, insufficient,
or unavailable. New research, however, is clarifying
developmental and neurobiological aspects of BPD,
and randomized controlled trials repeatedly demon-
strate that treatment works. This Congress is an invaluable forum for in-
ternational scientific and clinical collaboration on behalf of patients with
BPD.
John M. Oldham, M. D.
President-Elect, American Psychiatric Association
Dear Colleagues
This first International Congress on Borderline Person
ality Disorder is a major milestone in the advances of
our field, and especially in line with the purpose of
our organization, the International Society for the
Studies of Personality Disorders, ISSPD. This Con-
gress is a significant opportunity to integrate the re-
cent most extensive and multidisciplinary studies of
BPD, and to gather scientists and clinicians from all over the world to an
attractive site in the center of Europe. The initiative of the congress or
ganizers Drs. Bohus and Kienast is commendable, both timely and rele-
vant. On behalf of ISSPD I would like to express our support of this event
and of a very diverse and interesting program outline.
Elsa Ronningstam, Ph. D.
President International Society for the Study of Personality Disorders (ISSPD)
8Welcome Address
Borderline personality disorder – today a well approved psychiatric diagnosis
– had long been seen by psychoanalysts as a behavior of hardly treatable neu-
rotic patients. Thanks to the psychiatrists Stern and Knight who introduced the
label “borderline” this psychiatric picture finally received a clinical meaning.
Overall, it took decades to integrate the disturbance into the group of personal-
ity disorders. Much research was needed to understand the symptoms of this
disorder and its significant heritability to develop selective ways of successful
treatment. Today, with about 2 % of our population suffering from Borderline,
the disease is more common than schizophrenic diseases. About 80 % of the
affected people start psychiatric or psychotherapeutic treatment. Many university hospitals main-
tain specific borderline wards supervised by well-skilled therapists.
By now, we are well grounded in treating Borderline patients with effective psychotherapy as well
as using psychopharmacology. But why is Borderline so extraordinary to hold an international con-
gress on this topic? Widely known is the enormous impact of the clinical symptoms on patients and
on their affiliates. The diverse phenomenology within the clinical picture is intriguing due to distinct
individual personality components. However, the most important point is the strong influence the
development of diagnosis and effective treatment of Borderline personality disorder had on the
development of psychotherapy within psychiatry. Many studies contributed to the understanding of
Borderline and helped relate it to the Diagnostic and Statistical Manual of Mental Disorders (DSM).
Last but not least: the development of disorder-specific psychotherapeutic treatment models opened
the door for school independent ways of psychotherapeutic treatment in psychiatry. Nevertheless,
more research is needed to investigate Borderline personality disorder’s psychopathology and its
related neurobiology. In addition, the ambulant medical health care for Borderline patients is still
severely insufficient and has to be strongly improved.
Despite the enormous scientific improvements, Borderline personality disorder remains strongly
and unfairly stigmatized. Hence, it is necessary to increase the awareness of Borderline personality
disorder among people suffering from this disorder, their families, medical professionals and the
general public.
The first International Congress on Borderline Personality Disorder is a milestone in a long struggle
for adequate diagnosis, classification and treatment of a long underestimated disease. First of all,
Borderline patients should be credited for this conference to take place. With all their challenging
behavior they have forced the psychiatric community to forge ahead. Secondly, researchers in the
field of psychotherapy like Prof. Marsha Linehan have to be credited for this conference because of
their open-mindedness to search for completely new ways to do psychotherapy. And last but not
least, Prof. Martin Bohus has to be credited for his effort and success in bringing this conference to
Berlin. He already proved to be an excellent organizer on many occasions and he did it again here.
We are very proud to have this conference here in Germany.
Professor Frank Schneider, M. D., Ph. D.
President of the German Association for Psychiatry and Psychotherapy (DGPPN)
9Congress Organisation
Congress President The Congress will be organized in coopera-
Professor Martin Bohus, MD tion with
Central Institute of Mental Health (CIMH) Association for Research in Personality Disor-
J5 ders (ARPD)
68159 Mannheim, Germany Austrian Association for Psychiatry and Psycho-
therapy (ÖGPP)
Local President and Scientific Contact Central Institute of Mental Health, Mannheim
Thorsten Kienast, MD (CIMH)
Schön Klinik Hamburg-Eilbek European Psychiatric Association (EPA)
Department of Psychiatry European Society for the Study of Personality
Dehnhaide 120, 22081 Hamburg, Germany Disorders (ESSPD)
Charité Campus Mitte German Association for DBT (Dachverband Dia-
Charitéplatz 1, 10115 Berlin lektisch-Behaviorale Therapie e. V. – DDBT)
German Association for Psychiatry and Psycho-
Scientific Advisory Board therapy (DGPPN)
Arnoud Arntz, The Netherlands Gesellschaft zur Erforschung und Therapie von
Martin Bohus, Germany Persönlichkeitsstörungen (GePs)
Wies van den Bosch, The Netherlands International Society for the Study of Personali-
Unice Chen, USA ty Disorders (ISSPD)
John Clarkin, USA Swiss Association for Psychiatry and Psycho-
Emil Coccaro, USA therapy (SGPP)
Linda Dimeff, USA World Psychiatric Association (WPA)
Peter Fonagy, United Kingdom
HIATRIC ASS
Alan Fruzzetti, USA PS
YC O
CI
LD
AT
WOR
Sabine Herpertz, Germany
NIO
Andre Ivanoff, USA ww g
w. w or
panet.
Thorsten Kienast, Germany
Klaus Lieb, Germany
Marsha Linehan, USA
Paul Links, Canada
Tom Lynch, United Kingdom
Cesare Maffei, Italy
Shelley McMain, Canada
Antonia New, USA
Valery Porr, USA
Alexandra Phillipsen, Germany Congress and Exhibition Office
Babette Renneberg, Germany
Thomas Rinne, The Netherlands
Franz Resch, Germany CPO HANSER SERVICE GmbH
Christian Schmahl, Germany Paulsborner Str. 44
Ulrich Schweiger, Germany 14193 Berlin, Germany
Larry Siever, USA Phone: +49 – 30 – 300 669-0
Kenneth Silk, USA Fax: +49 – 30 – 300 669-50
Regina Steil, Germany Email: borderline-congress@cpo-hanser.de
Svenn Torgersen, Norway Web: www.borderline-congress.org
Peter Tyrer, United Kingdom
10Klinik für Psychiatrie und Psychotherapie
Chefarzt: Dr. med. Thorsten Kienast
Tel.: -----
Fax: -----
E-Mail: TKienast@schoen-kliniken.de
NEU: Spezialstation für Borderline Persönlichkeits-
störungen und komorbide Sucht,
Eröffnung Herbst
Universitäre Klinik für Psychosomatische
Medizin und Psychotherapie
Chefarzt: Prof. Dr. med. Dipl.-Psych. Bernd Löwe
Tel.: -----
Fax: -----
E-Mail: BLoewe@schoen-kliniken.de
Die Schön Klinik Hamburg Eilbek - im Herzen von Hamburg - ist als
akademisches Lehrkrankenhaus der Universität Hamburg mit über
Betten, über .... Mitarbeiterinnen und Mitarbeitern und über ....
Patienten im Jahr eines der größten Krankenhäuser in Hamburg.
Schön Klinik Hamburg Eilbek
Dehnhaide
Hamburg
www.schoen-kliniken.de/eil
11Die Rhein-Jura Klinik ist eine von der PKV anerkannte
private Akutklinik nach §107 (1) SGB V für Psychiatrie,
Psychosomatik und Psychotherapie.
Die modern ausgestattete Rhein-Jura Klinik in Bad Säckingen liegt im Dreieck
Freiburg, Basel und Zürich. Die Gegend Südschwarzwald und Schweizer Jura gilt
als eine der schönsten Regionen Europas. Von allen Richtungen ist die Klinik
PD Dr. med Michael Berner
Universitätsklinikum Freiburg bestens erreichbar.
Ärztlicher Direktor
der Rhein-Jura Klinik Die Synthese zwischen Ortslage, der sich in die Landschaft eingefügten Gebäude
und vor allen Dingen die hochqualifizierten Mediziner und Psychologen mit sehr
motivierten Mitarbeitern werden Sie rasch überzeugen, hier gut aufgehoben zu sein.
Die 115 Patientenzimmer sind komfortabel ausgestattet mit Balkon, Bad/Dusche,
TV und Telefon. Für die Internetnutzung steht eine modernst ausgestatte Mediathek
zur Verfügung.
Sowohl niedergelassene Ärzte als auch Kliniken können sofort eine
Prof. Dr. med. Mathias Berger Aufnahme in die Rhein-Jura Klinik veranlassen. Aufgenommen werden
Universitätsklinikum Freiburg Privatversicherte, Selbstzahler und Beihilfeberechtigte.
Wissenschaftlicher Beirat
der Rhein-Jura Klinik
Wir behandeln Wir bieten
Affektive Störungen Schlafstörungen › Rasche stationäre Aufnahme
› Depressionen › Schlafapnoe in Krisenfällen
› Akute Belastungsreaktion › Insomnie › Individualisierte störungs-
› Burn-Out-Syndrome › Restless-Leg-Syndrom spezifische Psychotherapie auf
Angststörungen Abhängigkeitsstörungen wissenschaftlicher Grundlage
› Traumafolgestörungen › Substanzen › Moderne Verhaltenstherapie
› Panikstörungen › Medikamente › Dialektisch Behaviorale Therapie
Prof. Dr. Martin Bohus › Cognitive Behavioral Analysis
› Zwangsstörungen › Spiel- und Internet-Sucht
Zentralinstitut für Seelische System of Psychotherapy (CBASP)
Gesundheit, Mannheim Somatoforme Störungen Persönlichkeitsstörungen › Achtsamkeitsbasierte Therapie
Wissenschaftlicher Beirat › Schmerzstörungen Essstörungen › Körper-Therapie
der Rhein-Jura Klinik
Kooperationspartner Rhein-Jura Klinik
Schneckenhalde 13 - 79713 Bad Säckingen
Telefon: +49(0) 7761-5600-0
Telefax: +49(0) 7761-5600-105
Email: info@rhein-jura-klinik.de
Internet: www.rhein-jura-klinik.de
®Format Descriptions, Topics and Programme Structure
Format Descriptions Topics
G Plenary Sessions (PL) 1. ADHD
Duration: 45 min 2. Adolescence
Eminent experts will present papers on the con- 3. Aggression
gress‘ main topics. 4. Animal Studies
5. Antisocial Behavior
G Symposia (S) 6. Anxiety Disorder
Each symposium at the congress is scheduled 7. Depression
for 90 minutes which equals four speakers 8. Dissociation
chaired by two scientists. 9. Dialectical Behavioural Therapy
10. Eating Disorders
G Practice Seminars (PS) 11. Emotion Regulation
Practice Seminars help to further broaden the 12. Epidemiology
participant‘s expertise in a particular field of 13. Family
knowledge. The duration of each course is 14. Genetic, Environment Interaction
either 90 or 180 minutes. The participation at 16. Mentalization Based Therapy
these courses is not included in the congress 17. Neurobiology
registration fee. 18. Nursing Care
19. Offsprings
G Oral presentations (OP) 20. Pharmacology
Duration: 10 min + 5 min 21. Psychodynamically Informed Psychiatric
The 90 minutes sessions are grouped by topics Care
and chaired by selected specialists. The time 22. Psychopathology
slot for a single presentation in a free communi- 23. PTSD
cation is 15 minutes including discussion time. 24. Schema Therapy
25. Selfharm and Pain
G Posters (P) 26 . Social Phobia
There will be eleven poster sessions during the 27. Substance Use Disorders
congress. The posters will be grouped into the- 28. Somatic Comorbidities
matic Guided Poster Tours chaired by renowned 29. Suicidality
specialists. The Guided Poster Tours will give 30. Transference Focussed Psychotherapy
the authors the opportunity to present their find
ings and discuss them with the audience. The Congress Language
best posters will be awarded. The official language of the 1st International
Congress on Borderline Personality Disorder is
G Round-Table (RT) English. A selection of sessions, marked with
Round-Table for specialists, affected persons , will be held in German. Sessions, marked
and interested people. with , will be held in English. Simultaneous
translation will be provided for selected ses-
sions only, marked with .
Programme Structure
The congress programme is sorted by topics (p. 20 – 24) and chronologically by days (p. 25 – 60).
For better orientation sessions within the scientific programme are differentiated by colour:
S Symposium P Poster Session
PS Practice Seminar SP Special Session
PL Plenary Session OP Oral Presentation
FS Further Session RT Round Table
The programme is sorted by G Day G Time and location G Session type
13Thu
01 Programme Overview
Hall / Saal C 01 Hall / Saal B 5 / 6 Hall / Saal B 7/8 Hall / Saal B 09 Hall / Saal A 01
9
S-001 What’s the S-002 Borderline S-003 Impulsive S-004 Deliber- S-005 The
difference that Personality Disor- Aggression in ate self-harm measurement of
makes the differ- der and ADHD – BPD: Genetics and personality borderline and
ence? … Differentialdiag- and Neurobiology development related character-
nosis, Comorbid- istics
10 ity and Treatment
11
PL-001 The epide-
miology of border-
line personality
Technical Exhibition: 09.00 – 17.00 h
disorder: …
PL-002 Dimensio
12 nal Assessments
for Borderline Per-
Registration Counter: 08.00 – 19.00 h
sonality …
P-001, P-002, P-003, P-004, P-005
13
Poster Session G Foyer on Level C
SP-001
Opening
14 Ceremony
15
OP-001 Diagnos OP-002 Comor- PS-106 Adoles PS-105 Early OP-003 Single
tics bidity cent Identity intervention for Cases and Treat-
Treatment: A borderline per- ment
new approach to sonality disorder
16 identifying and in youth
treating personal-
ity pathology in
adolescence
OP-004 Etiology OP-005 Adoles OP-006 Experi-
17 cents mental Psycho
pathology
18
OP-007 Symptom S-007 Emotional OP-008 Psy- OP-009 Psycho- S-008 Facets
Assessment Dysregulation in chodynamic therapy Trials of Impulsivity
19 Borderline Per Cases in BPD
sonality Disorder
20
Foyer on Level B: Get Together
14Thu
Programme Overview 01
Room / Room /
Hall / Saal A 03 Hall / Saal A 04 Hall / Saal A 05 Hall / Saal A 06 Raum B 03 Raum C 03
9
S-006 Co- PS-101 How to PS-102 DBT- PS-104 Skills PS-103 Arbeit
morbidity be mindful to ACES – Ein dia- für Therapeuten: mit der neuen
between BPD teach mindful- lektisch behavio- Wie wir uns in Skills-CD – Ver
and APD: ness? raler Ansatz zur Teamarbeit und änderungen im
Diagnostic and Verbesserung Supervision ge- Skillstraining
clinical issues der Lebensqua- genseitig effek- 10
lität von Patien tiv unterstützen
ten mit BPS können
11
12
FS-001
Opening Press
Conference
P-001, P-002, P-003, P-004, P-005 13
Poster Session G Foyer on Level C
14
15
PS-107 Work- PS-108 Treat- PS-109 Dialecti- PS-110 Behand- PS-111 DBT-
shop Schema ment of comor- cal Behavior lung komor- Essstörung
Therapy for bid ADHD in Therapy for bider AD(H)S
Borderline patients with Posttraumatic bei Patienten 16
Personality BPD Stress Disorder mit Borderline-
Disorder (DBT-PTSD) Persönlichkeits-
after childhood störung
sexual abuse: A
new treatment
17
18
PS-112 Schema PS-113 How to PS-114 Clini- PS-115 A frame- PS-116 Ein-
Mindfulness- manage attach- cal use of work for the führung in das
based cogni- ment trauma attachment treatment of the Skillstraining 19
tive therapy in borderline interviews in difficult to treat
(MBCT): How patients by the diagnostics person with
to incorporate Mentalization- of Borderline severe person-
mindfulness in Based Treat- Personality ality disorders
schematherapy? ment: … Disorders and …
20
Foyer on Level B: Get Together
15Fri
02 Programme Overview
Hall / Saal C 01 Hall / Saal B 5 / 6 Hall / Saal B 7/8 Hall / Saal B 09 Hall / Saal A 01
9
S-009 Treatment S-010 Dissozia- S-011 Trans S-012 Biological S-013 Adoles
of Posttraumatic tion –Neurobiolo ference-Focused studies and cence and bor-
Stress Disorder gische Mechanis psychotherapy: considerations in derline personal-
in patients suffer men und thera- State of the art borderline per ity: Experience
ing from Border- peutische sonality disorder from a European
10 line Personality Implikationen french-speaking
Disorder research network
11
PL-003 Epigenet-
ics in the control
of behavior
Technical Exhibtion: 09.00 – 17.00 h
PL-004 Neurobio-
12 logical Findings in
Borderline Person-
Registration Counter: 08.00 – 19.00 h
ality Disorders …
P-006, P-007, P-008, P-009, P-010, P-011
13
Poster Session G Foyer on Level C
S-014 Mentaliza S-015 Affective S-016 Memory S-017 Social S-018 From
tion-based treat- instability in alterations in cognitions and parenthood to
14 ment for border- borderline per patients with bor- emotions in the suicidality, diffe
line personality sonality disorder derline personal interpersonal rent aspects of
disorder: … ity disorder: … context care possibilities
in borderline per-
sonality disorder
15
OP-010 Treat SP-002 DSM-V: PS-122 Trans- PS-128 DBT PS-129 BPD
ment Develop Do we have to ference-Focused Mindfulness Rad- Psychoeducation:
ment and change the Psychotherapy ical Acceptance Collaborating for
Training course of DSM-V for Borderline and Willingness Change Family
16 PD work group Patients Members as
proposal? Round Clinical Allies
Table Debate
OP-011 Psycho- OP-012 Neuro
17 pathology biology
18
S-024 Findings S-025 Outpatient OP-013 PTSD S-026 Dialectical OP-014 Pharma-
from a Canadian DBT-treatment behavior therapy cology
19 randomized trial systems in for substance
comparing dialec- Europe abuse in individ-
tical behaviour uals with border-
therapy to general line personality
psychiatric man- disorder: …
agement: …
20
from 20.30 h: Congress Dinner at Restaurant Nolle
16Fri
Programme Overview 02
Hall / Saal A 03 Hall / Saal A 04 Hall / Saal A 05 Hall / Saal A 06 Room/Raum B 03
9
PS-117 Umgang PS-118 Group PS-119 DBT in der PS-120 Wie vermit- PS-121 Schema-
mit Grenzen und Schema Therapy Tagesklinik – Zwei tele ich Achtsam- therapie bei
Kontingenzen in for Borderline Per- Modelle keit? Borderline
der ambulanten sonality Disorder: Persönlichkeits
und stationären Model, Therapist störung
DBT Style, Core Tech 10
niques and Empiri-
cal Validation
11
12
P-006, P-007, P-008, P-009, P-010, P-011 13
Poster Session G Foyer on Level C
S-019 Neurobio- S-020 Neuroimag S-021 Basic mecha- S-022 Emotion S-023 Dialectical
logical Aspects of ing in adolescent nisms of aversive regulation in BPD: Behavior Therapy
Emotion, Motiva- borderline person- learning in BPD Assessment, psy- (DBT) training in 14
tion and Impulsive ality disorder chopathology and Europe: Sharing
Behavior from treatment the experience
Neuroimaging
Studies
15
PS-123 Einführung PS-124 DBT-A in PS-125 Grundlagen, PS-126 Dialektisch- PS-127 DBT-Eating
in die Dialektisch der stationären Behandlungs- Behaviorale Thera- Disorders
Behaviorale The Kinder- und methoden und pie der Posttrauma-
rapie bei Patienten Jugendpsychiatrie -instrumente der tischen Belastungs- 16
mit Borderline- Dialektisch-Behav- störung nach
Persönlich ioralen Therapie sexualisierter
keitsstörung und (DBT) im Rahmen Gewalt in der Kind-
komorbidem Sub- eines stationären heit – eine neue
stanzmissbrauch Therapiekonzeptes Behandlung
oder -abhängigkeit 17
(DBT-S)
18
S-027 Integrating PS-132 A Dialecti- PS-130 The use PS-131 DBT in PS-132 Körper
emotional regula cal Behavior Ther- of imagery in a komplementären therapie in der DBT
tion and psycho- apy with Parents schema group Arbeitsfeldern der 19
biological findings and Partners to therapy Sozialpsychiatrie –
in BPD Augment Individual Chancen, Grenzen
Outcomes und Konsequenzen
in Theorie und
Praxis
20
from 20.30 h: Congress Dinner at Restaurant Nolle
17Sat
03 Programme Overview
Hall / Saal C 01 Hall / Saal B 5 / 6 Hall / Saal B 7 / 8 Hall / Saal B 09 Hall / Saal A 01
9
S-028 New devel- S-029 New ap- RT-001 Round PS-138 Clinical S-030 Pharmaco
opments in proaches to iden- Table: Betroffe- subgroups of pa- therapy in Border-
Registration Counter: 08.00 – 12.00 h
Technical Exhibtion: 09.00 – 12.30 h
schema therapy tity disturbance: nen-Diskussions- tients with border- line Personal-
for Borderline Self-esteem and forum: Ich sehe line personality ity Disorder:
Personality Dis- self-concept in was, was Du nicht disorder: Descrip- Metaanalyses
10 order borderline person- siehst … tion, assessment and latest devel-
ality disorder … and specific inter- opments
vention strategies
11
PL-005 Mentaliza
tion Based Thera-
py – State of the
Art
PL-006 Dialectical
12 Behavior Therapy
(DBT): Where Are
We Now?
SP-003 Closing &
Award Ceremony
13
Room / Room /
Hall / Saal A 03 Hall / Saal A 04 Hall / Saal A 05 Hall / Saal A 06 Raum B 03 Raum B 95
9
PS-133 Psycho PS-134 Heal- PS-135 Modi- PS-136 Einfüh PS-137 Struktur S-031 Inter
education for ing insecure fied dialectical rung in Stepps und Inhalte für action of
patients with attachment behavior thera- die Pflege der disturbed pain
Borderline representations py for individu- Dialektisch- processing and
Personality Dis- and managing als with intellec- behavioralen self-injurious
10 order (BPD) emotions tual disabilities Therapie der behavior
Essstörung
11
12
18STEPPS – Erfolgreiches Emotionstraining für Menschen mit
Borderline-Persönlichkeitsstörungen
STEPPS (Systems STEPPS-Trainerfortbildung
Training for Emotio- STEPPS ist eine gute Ergänzung zu beste-
nal Predictability and henden therapeutischen Angeboten wie
Problem Solving) ist ein z. B. DBT. Man braucht keine psychothe-
strukturiertes Trainings- rapeutische Ausbildung, um mit diesem
programm für Menschen mit Borderline- Programm zu arbeiten.
Persönlichkeitsstörung. Es ist aber auch Um STEPPS effektiv einzusetzen, bietet
ein wirksames Angebot für alle, die an der Dachverband STEPPS Fortbildungen
einer Störung der Emotionsregulation an. Informieren Sie sich auf dem Kon-
leiden. Ziel ist, betroffene Menschen zu gress am Stand des Psychiatrie-Verlags
befähigen, mit professionellen Helfern, oder nehmen Sie an dem Praxis-Seminar
mit Angehörigen und Freunden klarer teil:
über ihre Erkrankung und die not- Samstag, 3. Juli 2010, 09.00 - 10.30 Uhr
wendigen Schritte zur Bewältigung zu Einführung in Stepps mit Dr. Ursula
kommunizieren. Im Rahmen einer festen Herrmann und Dr. Ewald Rahn
Gruppe mit Seminarcharakter erlernen
die Teilnehmerinnen und Teilnehmer
Fertigkeiten für einen besseren Umgang
mit ihren Emotionen und zur Steuerung
ihres Verhaltens.
STEPPS (Systems Training for Emotional Predictability and Problem
Solving) ist ein strukturiertes Trainingsprogramm für Menschen mit Border-
line-Persönlichkeitsstörung. Es ist aber auch ein wirksames Angebot für alle,
Die Materialien die an einer Störung der Emotionsregulation leiden. Ziel ist, betroffene
STEPPS Das Trainingsprogramm bei Borderline / Trainerhandbuch
Menschen zu befähigen, mit ihren Therapeuten, mit Angehörigen und
Freunden klarer über ihre Erkrankung und die notwendigen Schritte zur
Bewältigung zu kommunizieren. Darüber hinaus lernen die Teilnehmenden
Das Trainerhandbuch enthält die Moderatorenleit-
spezifische Fertigkeiten für einen angemesseneren Umgang mit ihren
Emotionen und zur Steuerung ihres Verhaltens.
STEPPS
Die Alltagsnähe des Emotionstrainings ist das ganz große Plus dieses
Ansatzes. Neben einem Problemlösetraining werden auch Fertigkeiten wie
das Essverhalten und die Freizeitgestaltung unter die Lupe genommen
linien für 20 Wochensitzungen sowie die ausgear- und neue Verhaltensweisen eingeübt.
Das Manual bezieht Angehörige und Freunde ein. Gemeinsam bilden sie das
Nancee S. Blum, Norman E. Bartels, Don St. John, Bruce M. Pfohl
»Helfer-Team«, das den Betroffenen bei den neu erworbenen Fertigkeiten
Das Trainingsprogramm
Blum, Bartels, St. John, Pfohl
stützt und fördert.
beiteten Unterrichtsstunden plus Downloads vieler STEPPS ist eine gute Ergänzung zu bestehenden therapeutischen Angeboten
wie z. B. DBT. Man braucht keine therapeutische Ausbildung, um mit diesem
Programm zu arbeiten.
bei Borderline
In den USA und in den Niederlanden wird STEPPS seit Jahren mit sehr Emotionale Krisen bewältigen,
Arbeitsmaterialien. Für Gruppen-Teilnehmende guten Ergebnissen eingesetzt. Ewald Rahn hat das Programm übersetzt und
gemeinsam mit Ursula Herrmann bearbeitet und erfolgreich in Warstein
evaluiert.
Probleme lösen, Alltag gestalten,
Beziehungen aufbauen
gibt es die Unterlagen als Loseblattsammlung im Trainer-Handbuch
Übersetzt und bearbeitet von Ewald Rahn und Ursula Herrmann
Ordner.
ISBN 978-3-88414-449-7
N. Blum, N. F. Bartels, D. St. John, B. Pfohl www.psychiatrie-verlag.de
STEPPS - Das Trainingsprogramm bei Borderline:
STEPPS
Emotionale Krisen bewältigen, Probleme lösen, Alltag Das Trainingsprogramm
Arbeitsbuch
STEPPSDas Trainingsprogramm/Arbeitsbuch
gestalten, Beziehungen aufbauen. Trainerhandbuch
ISBN 978-3-88414-449-7, 304 S., geb., 125.00 Euro
STEPPS - Arbeitsbuch
Übersetzt und bearbeitet von Ewald Rahn
im DIN A4-Ordner,
und Ursula Herrmann Emotionale Krisen bewältigen
Probleme lösen
Alltag gestalten
280 Seiten, 39.95 Euro
Bei Teilnahme an den Fortbildungen sind die Materialien
Beziehungen aufbauen
978-3-88414-499-2
in der Gebühr enthalten. www.dachverband-stepps.de www.dachverband-stepps.de
www.psychiatrie-verlag.de
www.dachverband-stepps.de
19Scientific Programme by Topic
1. ADHD 5. Antisocial Behavior
S-002 page 26 S-006 page 27
Borderline Personality Disorder and ADHD – Dif Co-Morbidity between BPD and APD:
ferentialdiagnosis, Comorbidity and Treatment Diagnostic and clinical issues
PS-108 page 34
Treatment of comorbid ADHD in patients with 6. anxiety disorder
BPD
P-004 page 31
PS-110 page 34 Anxiety Disorder
Behandlung komorbider AD(H)S bei Patienten
mit Borderline-Persönlichkeitsstörung
8. Dissociation
OP-002 page 35
Comorbidity S-010 page 41
Dissoziation – Neurobiologische Mechanismen
und therapeutische Implikationen
2. Adolescence
PS-101 page 28
S-013 page 42 How to be mindful to teach mindfulness?
Adolescence and borderline personality: Expe-
rience from a European french-speaking re- PS-103 page 28
search network Arbeit mit der neuen Skills-CD – Veränderun-
gen im Skillstraining
S-004 page 27
Deliberate self-harm and personality develop- PS-104 page 28
ment Skills für Therapeuten: Wie wir uns in Team
arbeit und Supervision gegenseitig effektiv un
S-020 page 50 terstützen können
Neuroimaging in adolescent borderline person-
ality disorder PS-120 page 43
Wie vermittele ich Achtsamkeit?
PS-105 page 33
Early intervention for borderline personality OP-010 page 53
disorder in youth Treatment Development and Training
OP-005 page 36
Adolescents 9. Dialectical Behavioural Therapy
P-010 page 46 S-001 page 26
Adolescence What’s the difference that makes the difference?
Commonalities and differences across effica-
cious treatments for BPD
3. Aggression
S-023 page 51
S-003 page 26 Dialectical Behavior Therapy (DBT) training in
Impulsive Aggression in BPD: Genetics and Europe: Sharing the experience
Neurobiology
S-008 page 38
Facets of Impulsivity in BPD
20 = Deutsch = EnglishScientific Programme by Topic
S-024 page 54 PS-131 page 56
Findings from a Canadian randomized trial com DBT in komplementären Arbeitsfeldern der
paring dialectical behaviour therapy to general Sozialpsychiatrie – Chancen, Grenzen und Kon-
psychiatric management: Predictors of drop- sequenzen in Theorie und Praxis
out, risk factors for suicide and patterns of
health care utilities PS-132 page 56
Körpertherapie in der DBT
S-025 page 55
Outpatient DBT-treatment systems in Europe PS-132 A page 56
Dialectical Behavior Therapy with Parents and
S-026 page 55 Partners to Augment Individual Outcomes
Dialectical behavior therapy for substance abuse
in individuals with borderline personality dis PS-133 page 59
order: Results from a multi-centre randomized Psychoeducation for patients with Borderline
controlled trial Personality Disorder (BPD)
PS-102 page 28 PS-135 page 59
DBT-ACES – Ein dialektisch behavioraler Ansatz Modified dialectical behavior therapy for indi-
zur Verbesserung der Lebensqualität von Pa- viduals with intellectual disabilities
tienten mit BPS
PS-136 page 59
PS-116 page 38 Einführung in Stepps
Einführung in das Skillstraining
PS-137 page 59
PS-117 page 43 Struktur und Inhalte für die Pflege der Dialek
Umgang mit Grenzen und Kontingenzen in der tisch-behavioralen Therapie der Essstörung
ambulanten und stationären DBT
P-006 page 43
PS-119 page 43 Dialectical Behavioural Therapy
DBT in der Tagesklinik – Zwei Modelle
PS-123 page 52 10. Eating Disorders
Einführung in die Dialektisch Behaviorale The
rapie bei Patienten mit Borderline-Persönlich PS-111 page 34
keitsstörung und komorbidem Substanzmiss- DBT-Essstörung
brauch oder -abhängigkeit (DBT-S)
PS-127 page 52
PS-124 page 52 DBT-Eating Disorders
DBT-A in der stationären Kinder- und Jugend
psychiatrie
11. Emotion Regulation
PS-125 page 52
Grundlagen, Behandlungsmethoden und -instru S-007 page 37
mente der Dialektisch-Behavioralen Therapie Emotional Dysregulation in Borderline Person-
(DBT) im Rahmen eines stationären Therapie- ality Disorder
konzeptes
S-015 page 49
PS-128 page 52 Affective instability in borderline personality
DBT Mindfulness Radical Acceptance and Wil disorder
lingness
= Deutsch = English 21Scientific Programme by Topic
S-022 page 51 14. genetic, environment
Emotion regulation in BPD: Assessment, psy- interaction
chopathology and treatment
P-001 page 29
S-027 page 55 Genetic, Environment Interaction
Integrating emotional regulation and psycho-
biological findings in BPD
15. Healthcare and Economics
PS-112 page 38
Schema Mindfulness-based cognitive therapy P-011 page 47
(MBCT): How to incorporate mindfulness in Healthcare and Economics
schematherapy?
PS-114 page 38 16. Mentalization Based Therapy
Clinical use of attachment interviews in the
diagnostics of Borderline Personality Disorders S-014 page 48
Mentalization-based treatment for borderline
PS-115 page 38 personality disorder: A summary of the evi-
A framework for the treatment of the difficult to dence, new evidence and recent developments in
treat person with severe personality disorders different dosages and treatment population
and substance use disorder
PS-113 page 38
PS-134 page 59 How to manage attachment trauma in border-
Healing insecure attachment representations line patients by Mentalization-Based Treatment:
and managing emotions Therapeutical relationship and setting
P-005 page 32
Emotion Regulation 17. Neurobiology
S-011 page 41
12. Epidemiology Transference-Focused psychotherapy: State of
the art
OP-004 page 36
Etiology S-012 page 42
Biological studies and considerations in border-
OP-009 page 40 line personality disorder
Psychotherapy Trials
S-021 page 51
Basic mechanisms of aversive learning in BPD
13. Family
S-016 page 49
PS-129 page 52 Memory alterations in patients with borderline
BPD Psychoeducation: Collaborating for Change personality disorder: Experimental research and
Family Members as Clinical Allies clinical implications
S-019 page 50
Neurobiological Aspects of Emotion, Motivation
and Impulsive Behavior from Neuroimaging
Studies
OP-008 page 39
Psychodynamic Cases
22 = Deutsch = EnglishScientific Programme by Topic
OP-012 page 54 OP-006 page 37
Neurobiology Experimental Psychopathology
P-003 page 30 OP-007 page 38
Neurobiology Symptom Assessment
page 53
OP-011
20. Pharmacology Psychopathology
S-030 page 58 P-002 page 29
Pharmacotherapy in Borderline Personality Dis- Psychopathology
order: Metaanalyses and latest developments
OP-014 page 57 23. PTSD
Pharmacology
S-009 page 41
Treatment of Posttraumatic Stress Disorder in
21. Psychodynamically patients suffering from Borderline Personality
Informed Psychiatric Care Disorder
OP-003 page 35 PS-109 page 34
Single Cases and Treatment Dialectical Behavior Therapy for Posttraumatic
Stress Disorder (DBT-PTSD) after childhood
OP-001 page 34 sexual abuse: A new treatment
Diagnostics
PS-121 page 43
P-008 page 45 Schematherapie bei Borderline Persönlichkeits
Psychodynamically Informed Psychiatric Care störung
PS-126 page 52
22. Psychopathology Dialektisch-Behaviorale Therapie der Posttrau-
matischen Belastungsstörung nach sexualisier
S-005 page 27 ter Gewalt in der Kindheit – eine neue Behand-
The measurement of borderline and related lung.
characteristics
OP-013 page 56
S-017 page 49 PTSD
Social cognitions and emotions in the interper-
sonal context
24. Schema Therapy
S-029 page 58
New approaches to identity disturbance: Self- S-028 page 58
esteem and self-concept in borderline personal- New developments in schema therapy for Bor-
ity disorder and their relevance to psychothera- derline Personality Disorder
py
PS-107 page 33
PS-138 page 60 Workshop Schema Therapy for Borderline Per-
Clinical subgroups of patients with borderline sonality Disorder
personality disorder: Description, assessment
and specific intervention strategies
= Deutsch = English 23Scientific Programme by Topic
PS-118 page 43 27. Substance Use Disorders
Group Schema Therapy for Borderline Person-
ality Disorder: Model, Therapist Style, Core Tech P-007 page 44
niques and Empirical Validation Anxiety Disorder
PS-130 page 56
The use of imagery in a schema group therapy 29. Suicidality
S-018 page 50
25. Selfharm and Pain From parenthood to suicidality, different as-
pects of care possibilities in borderline person-
S-031 page 59 ality disorder
Interaction of disturbed pain processing and
self-injurious behavior
30. Transference Focussed Psycho-
therapy
PS-106 page 33
Adolescent Identity Treatment: A new approach
to identifying and treating personality pathology
in adolescence
PS-122 page 52
Transference-Focused Psychotherapy for Bor
derline Patients
P-009 page 46
Behandlungsentwicklung
Please visit the Technical Thu, 01 July 2010 09.00 – 17.00 h
Fri, 02 July 2010 09.00 – 17.00 h
Exhibition on Level B Sat, 03 July 2010 09.00 – 12.30 h
24 = Deutsch = EnglishPlenary Sessions
Thursday, 1 July
PL-001 Plenary Session PL-002 Plenary Session
11.00 – 11.45 h // Hall C 01 11.45 – 12.30 h // Hall C 01
The epidemiology of borderline personality Dimensional Assessments for Borderline Per
disorder: the state of the art sonality Disorder in DSM-5
G Peter Tyrer G Andrew E. Skodol
Imperial University, Community Psychiatry University of Arizona, Sunbelt Collaborative
(London, United Kingdom) (Tucson, USA)
Moderation: Martin Bohus (Mannheim, Moderation: John Oldham (Houston, USA)
Germany)
Friday, 2 July
PL-003 Plenary Session PL-004 Plenary Session
11.00 – 11.45 h // Hall C 01 11.45 – 12.30 h // Hall C 01
Epigenetics in the control of behavior Neurobiological Findings in Borderline Per-
G Moshe Szyf sonality Disorders – State of the Art
McGill University, Pharmacology and G Sabine C. Herpertz
Therapeutics (Montreal, Canada) Universität Heidelberg, Klinik für Allgemeine
Moderation: Ulrich Schweiger (Lübeck, Psychiatrie (Heidelberg, Germany)
Germany) Moderation: Christina Schmahl (Mannheim,
Germany)
Saturday, 3 July
PL-005 Plenary Session PL-006 Plenary Session
11.00 – 11.45 h // Hall C 01 11.45 – 12.30 h // Hall C 01
Mentalization Based Therapy – State of the Dialectical Behavior Therapy (DBT): Where
Art Are We Now?
G Peter Fonagy G Marsha Linehan
UCL Psychoanalysis Unit, Research Dept. of University of Washington, Dept. of Psychology
Clinical, Educational and Health Psychology (Washington, USA)
(London, United Kingdom) Moderation: Thorsten Kienast (Hamburg,
Moderation: Sabine C. Herpertz (Heidelberg, Germany)
Germany)
= Deutsch = English 25Thu
01 Scientific Programme by Day
S-001 Symposium 002
ADHD as an aggravating factor in adults with
09.00 – 10.30 h // Hall C 01
BPD
Topic 9: Dialectical Behavioural Therapy
A. Philipsen, Universitätsklinikum Freiburg, Psy-
What’s the difference that makes the differ- chiatrie und Psychotherapie (Freiburg, Germany)
ence? Commonalities and differences across
efficacious treatments for BPD 003
Chair: L. Dimeff (Seattle, USA) Emotion dysregulation and impulsivity in BPD
Co-Chair: V. Porr (New York, USA) and ADHD: comparative fMRI studies
O. Tüscher, Universitätsklinikum Freiburg, Psy-
001 chiatrie & Psychotherapie (Freiburg, Germany)
Mentalization based treatment (MBT) and its K. Bader, G. Jacob, K. Lieb
relationship to other psychotherapies for bor- 004
derline personality disorder ADHD in female offenders: prevalence, psy-
A. Bateman, St. Ann‘s Hospital, VISPD (London, chiatric co-morbidity and psychosocial impli-
United Kingdom) cations
002 W. Retz, Universitätsklinikum Homburg
Transference Focused Psychotherapy (TFP) (Homburg, Germany)
F. Yeomans, (USA)
003 S-003 Symposium
Dialectical Behavior Therapy 09.00 – 10.30 h // Hall B 7/8
L. Dimeff, BTECH Research, Inc., Research Inst. Topic 3: Aggression
(Seattle, USA) Impulsive Aggression in BPD: Genetics and
Neurobiology
004
TARA DBT-MBT Family Training Chair: L. Siever (New York, USA)
V. Porr, TARA, Research Inst. (New York, NY, Co-Chair: C. Schmahl (Mannheim, Germany)
USA)
001
Discussant: G. Feinberg (USA)
New genetic findings in aggression and BPD
J. Oldham, The Menninger Clinic, Psychiatry and
J. Kennedy, (Toronto, Ont., Canada)
Behavioral (Houston, USA)
002
S-002 Symposium Social and emotional processing in personal
ity disorder and aggression
09.00 – 10.30 h // Hall B 5/6
E. Coccaro, (Chicago, USA)
Topic 1: ADHD
Borderline Personality Disorder and ADHD- 003
Differentialdiagnosis, Comorbidity and Treat- Glutamate levels in the anterior cingulate cor-
ment tex correlate with self-reported impulsivity in
Chair: A. Philipsen (Freiburg, Germany) patients with borderline personality disorder
Co-Chair: S. Matthies (Freiburg, Germany) and healthy controls
C. Schmahl, ZI für Seelische Gesundheit, Psycho-
001 somatische Medizin (Mannheim, Germany)
Borderline Personality Disorder and child- M. Hoerst, G. Ende, M. Bohus
hood ADHD: Putting a controversial issue in a 004
developmental perspective Circuitry and Genetics of Aggression in BPD
A. Fossati, Vita-Salute San Raffaele Univ. (Milan, L. Siever, Mount Sinai School of Medicine, Dept.
Italy) of Psychiatry (New York, USA)
S. Borroni, C. Maffei
26 = Deutsch = EnglishThu
Scientific Programme by Day 01
S-004 Symposium S-005 Symposium
09.00 – 10.30 h // Hall B 09 09.00 – 10.30 h // Hall A 01
Topic 2: Adolescence Topic 22: Psychopathology
Deliberate self-harm and personality devel- The measurement of borderline and related
opment characteristics
Chair: R. Brunner (Heidelberg, Germany) Chair: R. Bell (Melbourne, Australia)
Co-Chair: F. Resch (Heidelberg, Germany) Co-Chair: A. Chanen (Melbourne, Australia)
001
001
The latent structure of borderline criteria:
Psychopathology and psychopathy in adoles-
Categorical, dimensional, or both?
cent male and female detainees
R. Bell, University of Melbourne, Psychological
K. Sevecke, Universitätsklinik Köln, Kinder- und
Sciences (Melbourne, Australia)
Jugendpsychiatrie (Cologne, Germany)
M. Krischer 002
Confirmatory factor and item response theory
002
analyses of the borderline personality ques-
Self-harming and suicidal behaviour in ado-
tionnaire
lescents – is there a gender-specific predispo-
J. Boldero, University of Melbourne, Orygen
sition?
Youth Health (Melbourne, Australia)
M. Kaess, Med. Universität Heidelberg, Kinder-
und Jugendpsychiatrie (Heidelberg, Germany) 003
P. Parzer, J. Haffner, J. Roos, M. Klett, R. Brunner, The structure of the Difficulties in Emotion
F. Resch Regulation Scale and relationships with bor-
derline personality disorder features
003
C. Hulbert, University of Melbourne, Orygen
Psychopharmacotherapy improves psychoso-
Youth Health (Melbourne, Australia)
cial functioning in adolescents with border-
line personality disorder 004
L. Wöckel, Universitätsklinik Aachen, Kinder- The relationship of borderline personality dis-
und Jugendpsychiatrie (Aachen, Germany) order to other personality disorders
K. Goth, F. D. Zepf, N. Matic, B. Herpertz- R. Mulder, University of Otago, Orygen Youth
Dahlmann, F. Poustka Health (Christchurch, New Zealand)
004
Pain Perception in female adolescents diag- S-006 Symposium
nosed with Borderline Personality Disorder 09.00 – 10.30 h // Hall A 03
(BPD): Results from a study using quantitative Topic 5: Antisocial Behavior
sensory testing Co-Morbidity between BPD and APD: Diag-
C. von Kalckreuth, Med. Universität Heidelberg, nostic and clinical issues
Kinder- und Jugendpsychiatrie (Heidelberg, Chair: A. Ivanoff (New York, USA)
Germany) Co-Chair: L. van den Bosch (Deventer, The
Netherlands)
001
Co-morbidity between Borderline and Antiso-
cial Personality Disorders: Other Axis II diag-
noses and disturbances
M. P. Heyes, Columbia University, School of
Social Work (New York, USA)
= Deutsch = English 27Thu
01 Scientific Programme by Day
002 PS-104 Practice Seminar
Antisocial and Borderline Characteristics in
09.00 – 10.30 h // Hall A 06
Stalking Offenders: Examining a Clinical
Skills für Therapeuten: Wie wir uns in Team
Sample
arbeit und Supervision gegenseitig effektiv
A. Ivanoff, Columbia University, School of Social
unterstützen können
Work (New York, USA)
F. Mayer-Bruns (Freiburg, Germany)
003
DBT for co-occurring borderline personality
disorder and antisocial personality disorder in PL-001 Plenary Session
a maximum security women‘s correctional fa- 11.00 – 11.45 h // Hall C 01
cility The epidemiology of borderline personality
S. Manning, Behavioral Tech., LLC (Seattle, USA) disorder: the state of the art
004 Peter Tyrer, Imperial University, Community
Dialectical Behaviour Therapy, Forensic pa- Psychiatry (London, United Kingdom)
tients and forensic staff: Is changing the atti- Moderation: Martin Bohus (Mannheim,
tude effective? Germany)
L. van den Bosch, Dialexis, Dept. of Psychology
(Deventer, The Netherlands)
PL-002 Plenary Session
11.45 – 12.30 h // Hall C 01
PS-101 Practice Seminar
Dimensional Assessments for Borderline Per
09.00 – 10.30 h // Hall A 04 sonality Disorder in DSM-5
Topic 8: Dissociation Andrew E. Skodol, University of Arizona,
How to be mindful to teach mindfulness? Sunbelt Collaborative (Tucson, USA)
K. Schehr (Freiburg, Germany) Moderation: John Oldham (Houston, USA)
E. Max (Freiburg, Germany)
FS-001 Further Session
PS-102 Practice Seminar 12.00 – 13.00 h // Room C 03
09.00 – 10.30 h // Hall A 05 Eröffnungspressekonferenz /
Topic 9: Dialectical Behavioural Therapy Opening Press Conference
DBT-ACES – Ein dialektisch behavioraler Moderation: T. Nesseler (Berlin, Germany)
Ansatz zur Verbesserung der Lebensqualität M. Bohus (Mannheim, Germany)
von Patienten mit BPS F. Schneider (Aachen, Germany)
K. Höschel (Münster, Germany) T. Rinne (Utrecht, The Netherlands)
A. Link (Nürnberg, Germany)
T. Kienast (Hamburg, Germany)
PS-103 Practice Seminar
09.00 – 10.30 h // Room B 03
Topic 8: Dissociation
Arbeit mit der neuen Skills-CD – Veränderun-
gen im Skillstraining
T. Grathwol (Koenigsfeld, Germany)
C. Fuhrhans (Littenheid, Switzerland)
28 = Deutsch = EnglishSie können auch lesen
